With pemphigus, the immune system attacks the organism: It attacks a group of proteins that is necessary for the cohesion of skin cells with antibodies. The usually tight cell structure dissolves, cavities that fill with fluids develop in the skin. Thin-walled blisters form out of this.
"The most dangerous thing about this disease is that it destroys the skin's barrier function", says Jens Waschke, Professor for Anatomy. The body threatens to desiccate, furthermore, dangerous bacteria can enter and cause blood poisoning.
The rare disease mostly affects people between 40 and 70: About 80 cases are recorded in Germany per year. The chronic condition is currently being treated with cortisone and other drugs that suppress the immune system. "This, however, leads to sometimes severe side effects that justify the search for new therapies", thinks the professor.
Damaging effects of antibodies diminished
Fighting the dangerous antibodies in the patient's organism: In the Journal of Biological Chemistry, Waschke, his colleague Detlev Drenckhahn and further researchers from Würzburg describe how this could work in principle.
The team was able to significantly reduce the damaging effects of the antibodies in cell cultures. This was accomplished with small, protein-like molecules (peptides) that were constructed specifically for this purpose: They lower the degree in which the skin cells break apart under the influence of the antibodies by about half.
Next, the scientists have to test if this positive effect can also be achieved in living skin tissue. Should additional studies succeed, they possibly show the way to a new therapy against pemphigus. "We cannot administer the peptides themselves to humans because they could possibly cause immune reactions", explains Jens Waschke. Instead, a molecule has to be discovered that is structurally similar to the peptides and also has a similarly positive effect.
Pemphigus as a model disease
The researchers in Würzburg do not only focus on new therapies against the disease. They also want to gain fundamental insights. "Pemphigus is an important model to study which role antibodies play in the development of autoimmune diseases", says Jens Waschke. "Furthermore, we use the antibodies as tools to research the structure and regulation of contacts between cells."
Waschke emphasises that the interdisciplinary cooperation in the Special Research Area 487 in Würzburg is jointly responsible for the success of the research. Through computer modelling, biophysicist Thomas Müller figured out which structures the peptides must have to be effective. Chemist Athina Efthymiadis synthesized the peptides, biomedical scientist Wolfgang-Moritz Heupel carried out the experiments with an atomic force microscope.
Enno Schmidt from the dermatology clinic, who has transferred to Lübeck in the meantime, acted as the link to the medical area: He isolated the damaging antibodies from the blood of a pemphigus patient.
Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus; Wolfgang-Moritz Heupel, Thomas Müller, Athina Efthymiadis, Enno Schmidt, Detlev Drenckhahn, and Jens Waschke. The Journal of Biological Chemistry, Vol. 285, No. 13, pp 8589-8595, March 27, 2009, DOI 10.1074/jbc.M808813200
For further information
Professor Jens Waschke, ++49 (931) 31-2707, firstname.lastname@example.org
Robert Emmerich | idw
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy